应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ADHD Alcobra Ltd.
退市 11-19 12:53:46 EST
10.22
+0.00
0.00%
最高
10.22
最低
10.22
成交量
0.00
今开
10.22
昨收
10.22
日振幅
0.00%
总市值
2.82亿
流通市值
9,076万
总股本
2,756万
成交额
0.00
换手率
0.00%
流通股本
888.10万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
武田掀起新一轮裁员潮!专利悬崖、管线调整之后,整合能否找到出路?
医药经济报 · 10-27
武田掀起新一轮裁员潮!专利悬崖、管线调整之后,整合能否找到出路?
奢侈品之王,盯上AI创业小公司,一口气投了5家
创业邦 · 09-29
奢侈品之王,盯上AI创业小公司,一口气投了5家
SBF审判期间行为新解:自闭症与注意力缺陷障碍
金色精选 · 09-24
SBF审判期间行为新解:自闭症与注意力缺陷障碍
【多位医生提交法庭之友简报,称SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。
金色财经 · 09-24
【多位医生提交法庭之友简报,称SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。
【医学专家:SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。
金色财经 · 09-24
【医学专家:SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。
美国允许增加武田多动症药物的产量以解决短缺问题
Reuters · 09-04
美国允许增加武田多动症药物的产量以解决短缺问题
美国允许增加武田多动症药物的产量以解决短缺问题
Reuters · 09-04
美国允许增加武田多动症药物的产量以解决短缺问题
环线制药在制备FDA营销许可证过程中在其ADHD药物CTX-1301的制造方面实现了重要的里程碑。
智通财经 · 06-25
环线制药在制备FDA营销许可证过程中在其ADHD药物CTX-1301的制造方面实现了重要的里程碑。
Akili宣布Endeavorotc获得FDA授权这是首个通过视频游戏数字治疗成年ADHD的FDA认可。
智通财经 · 06-19
Akili宣布Endeavorotc获得FDA授权这是首个通过视频游戏数字治疗成年ADHD的FDA认可。
京东健康与正官庄"中韩人参研讨会"发布相关研究成果
美通社 · 05-28
京东健康与正官庄"中韩人参研讨会"发布相关研究成果
加载更多
公司概况
公司名称:
Alcobra Ltd.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Alcobra Ltd.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。
发行价格:
--
{"stockData":{"symbol":"ADHD","market":"US","secType":"STK","nameCN":"Alcobra Ltd.","latestPrice":10.22,"timestamp":1510952400000,"preClose":10.22,"halted":4,"volume":0,"delay":0,"floatShares":8881019,"shares":27563000,"eps":-0.89,"marketStatus":"退市","marketStatusCode":2,"change":0,"latestTime":"11-19 12:53:46 EST","open":10.22,"high":10.22,"low":10.22,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.89,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1732050000000},"adr":0,"adjPreClose":10.22,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/ADHD","defaultTab":"news","newsList":[{"id":"2478151690","title":"武田掀起新一轮裁员潮!专利悬崖、管线调整之后,整合能否找到出路?","url":"https://stock-news.laohu8.com/highlight/detail?id=2478151690","media":"医药经济报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478151690?lang=zh_cn&edition=full","pubTime":"2024-10-27 18:56","pubTimestamp":1730026591,"startTime":"0","endTime":"0","summary":"武田制药在经历今年多轮裁员后,正计划进一步缩减员工规模。业内人士分析,武田制药近期的裁员决策主要是受到专利到期所带来的市场冲击及其对财务状况的影响。对武田制药而言,当务之急是寻找并推出下一代的主力产品。尽管武田制药通过专利诉讼试图延缓Vyvanse的专利到期,但这一努力并未能有效缓解利润下降的压力。自公布重组计划以来,武田制药已经启动了一连串的裁员措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241027190022a1eef4bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241027190022a1eef4bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4116","IG","TAK","CD","BK4007","ADHD","IBD"],"gpt_icon":0},{"id":"2471888452","title":"奢侈品之王,盯上AI创业小公司,一口气投了5家","url":"https://stock-news.laohu8.com/highlight/detail?id=2471888452","media":"创业邦","labels":["Company Corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2471888452?lang=zh_cn&edition=full","pubTime":"2024-09-29 11:00","pubTimestamp":1727578800,"startTime":"0","endTime":"0","summary":"财大气粗的奢侈品巨头,拥抱起AI来一点不逊于VC。LV老板今年一口气投了5家AI公司LVMH集团是全球市值最大的奢侈品公司,据2024福布斯全球亿万富豪榜,阿尔诺身家达到2330亿美元,而其家族财富值已位居世界第一。据私人财富情报平台Fintrx称,这些AI公司的融资总额超过了3亿美元。预计从2022年到2027年,AI主题市场将增长15倍,复合年增长率为72%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://mp.weixin.qq.com/s?__biz=MjM5OTAzMjc4MA==&mid=2650767848&idx=1&sn=c460996088ffbc1574046bfa71c7cdd5&chksm=bf2afb7fa886144422c9c5cf627604198b9623792bf86637e06fd9a11c26bc59a7010333df97&scene=0#rd","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Company Corporation","news_rank":0,"length":0,"strategy_id":0,"source":"weixin_highlight","symbols":["LU0096364046.USD","LU0096362180.USD","IE00B3S45H60.SGD","BK4507","AMZN","LU0068578508.USD","IE00BKDWB100.SGD","IE00BKVL7J92.USD","IE00B775H168.HKD","IE00BKPKM429.USD","IE0004445239.USD","LU0149725797.USD","LU0130103400.USD","IE00BJJMRX11.SGD","BK4538","MSFT","IE00B1XK9C88.USD","LU0496367417.USD","NFLX","LU0128525929.USD","LU0097036916.USD","LU0127658192.USD","LU0175139822.USD","BK4587","BK4561","ADHD","LU0211328371.USD","LU0215105999.USD","BK4077","BK4514","IE00BFXG0V08.USD","IE00BN29S564.USD","IE00BJLML261.HKD","IE00BYQQ9H92.USD","IE00BJTD4N35.SGD","LU0225283273.USD","LU0724617625.USD","BK4017","AGI","BK4566","GOOGL","IE0034235188.USD","LU0061474960.USD","LU0211327993.USD","IE00BJTD4V19.USD","BK4550","IE00B5949003.HKD","IE0004445015.USD","BK4576","GOOG","IE00B775SV38.USD","BK4585","LU0079474960.USD"],"gpt_icon":1},{"id":"2469960480","title":"SBF审判期间行为新解:自闭症与注意力缺陷障碍","url":"https://stock-news.laohu8.com/highlight/detail?id=2469960480","media":"金色精选","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469960480?lang=zh_cn&edition=full","pubTime":"2024-09-24 12:40","pubTimestamp":1727152830,"startTime":"0","endTime":"0","summary":"医生在最近的一份法庭之友陈述书中写道,由于萨姆·班克曼-弗里德患有自闭症和注意力缺陷障碍,法庭和陪审团可能误解了他在刑事审判期间的行为。","market":"us","thumbnail":"data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAABgAAAAYCAYAAADgdz34AAAACXBIWXMAABYlAAAWJQFJUiTwAAAAAXNSR0IArs4c6QAAAARnQU1BAACxjwv8YQUAAAH5SURBVHgB7VXBUQJBEJxZqiykfFwGnhGIEQgZyEMt/HAbgRgBEIESwcLLAh+QgWQARCBmwAstq7h15m454Gr3OP7Mi73d6Z7p7R0ATnEgMM8hpd59AFEGCL34i1hS6kLKh9mhXHSDKk+Ii2etw4CWvuPYgiAmWq87UtYXuQn6/Y+W1roJoL0U0HeUhOLakJYTIBTtRuO+k0nAUiAWFAFXeE0kXZKj55Iilg7aBN4wn2bUcW23G9wHF59cGQHPCTjIo3E6l7slkuqGBOMDykMsTbfgPxUp5RKOCKVGhPHHJOW4k1WVMUTEgqXWIXAugioNlBrc2QikrC21PqsyOJMYTEClhrTQ03Rr6ej1Bl+wdROdXd3YC4nuccoGYTyBCK+8QQun1UzV/s4n+l10dFLnQiM3EVFLbLfQA2eElj2dcUfbPcGPJGbDlrGdJYpjiN5CEvSKn8a2k8ZRkf5aw4ugliax34FcIEZ8mekkvsAgeLyihBq1L1l/OzjnIhOzYbpsc2NTu8XgiIjBzyekBL/yxARiUyG/QCMDW2zqlssGPizvg4dJgZZRIUaQzBjsZQ0yY3EeE01znueVtI6KFFF7c1EmZqayeZSEhUszr3wDQwqsSfN6O42VMa6TQXYLGeOaSPsAv2+uO8v5h8Maa3//DyecuaQ7xVHxD4rDJjfZUTFuAAAAAElFTkSuQmCC","type":0,"news_type":0,"thumbnails":["data:image/png;base64,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"],"rights":{"source":"jinse_stock","url":"https://www.jinse.cn/blockchain/3698154.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.jinse.cn/blockchain/3698154.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_stock","symbols":["ABVC","ADHD","BK4139"],"gpt_icon":0},{"id":"2469948105","title":"【多位医生提交法庭之友简报,称SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。","url":"https://stock-news.laohu8.com/highlight/detail?id=2469948105","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469948105?lang=zh_cn&edition=full","pubTime":"2024-09-24 11:47","pubTimestamp":1727149638,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["ADHD","ABVC","BK4139"],"gpt_icon":0},{"id":"2469436685","title":"【医学专家:SBF的神经分化导致其在审判中被“误解”】金色财经报道,8位专注于神经分化领域的医生在近日支持SBF的法庭之友简报中告诉第二巡回上诉法院,SBF被诊断患有自闭症谱系障碍(ASD)和注意力缺陷/多动障碍(ADHD),这“在此案的诉讼过程中构成了严重挑战”,法庭和陪审团可能误解了SBF在刑事审判期间的行为。","url":"https://stock-news.laohu8.com/highlight/detail?id=2469436685","media":"金色财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469436685?lang=zh_cn&edition=full","pubTime":"2024-09-24 11:47","pubTimestamp":1727149638,"startTime":"0","endTime":"0","summary":null,"market":null,"thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.jinse.com/noah/v2/lives","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinse_live","symbols":["BK4139","ABVC","ADHD"],"gpt_icon":0},{"id":"2464832025","title":"美国允许增加武田多动症药物的产量以解决短缺问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2464832025","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464832025?lang=zh_cn&edition=full","pubTime":"2024-09-04 18:57","pubTimestamp":1725447431,"startTime":"0","endTime":"0","summary":" 路透9月4日 - 美国缉毒署 已将武田制药 的多动症药物Vyvanse及其仿制药的生产限额提高了约24%,以解决该药在美国持续短缺的问题。美国食品和药物管理局在2022年10月警告 ,以色列制药商Teva Pharmaceutical Industries的 Adderall因生产延误而出现短缺。这导致需求激增,武田的Vyvanse随之出现短缺。Vyvanse又名利眠宁,被美国缉毒署列为第二类管制药物,适用于被认为极有可能被滥用的药物,并规定了额外的处方保障措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","VTRS","BK4007","BK4583","LU2087621335.USD","LU1839511570.USD","BK4585","ADHD"],"gpt_icon":0},{"id":"2464202563","title":"美国允许增加武田多动症药物的产量以解决短缺问题","url":"https://stock-news.laohu8.com/highlight/detail?id=2464202563","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464202563?lang=zh_cn&edition=full","pubTime":"2024-09-04 18:57","pubTimestamp":1725447431,"startTime":"0","endTime":"0","summary":" 路透9月4日 - 美国缉毒署 已将武田制药 的多动症药物Vyvanse及其仿制药的生产限额提高了约24%,以解决该药在美国持续短缺的问题。美国食品和药物管理局在2022年10月警告 ,以色列制药商Teva Pharmaceutical Industries的 Adderall因生产延误而出现短缺。这导致需求激增,武田的Vyvanse随之出现短缺。Vyvanse又名利眠宁,被美国缉毒署列为第二类管制药物,适用于被认为极有可能被滥用的药物,并规定了额外的处方保障措施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1839511570.USD","VTRS","BK4583","LU2087621335.USD","BK4007","BK4585","BK4588","ADHD"],"gpt_icon":0},{"id":"2446846680","title":"环线制药在制备FDA营销许可证过程中在其ADHD药物CTX-1301的制造方面实现了重要的里程碑。","url":"https://stock-news.laohu8.com/highlight/detail?id=2446846680","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2446846680?lang=zh_cn&edition=full","pubTime":"2024-06-25 21:20","pubTimestamp":1719321600,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","BK1574","BK1191","ABVC","01477","ADHD"],"gpt_icon":0},{"id":"2444450492","title":"Akili宣布Endeavorotc获得FDA授权这是首个通过视频游戏数字治疗成年ADHD的FDA认可。","url":"https://stock-news.laohu8.com/highlight/detail?id=2444450492","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2444450492?lang=zh_cn&edition=full","pubTime":"2024-06-19 04:01","pubTimestamp":1718740860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","ADHD","ABVC"],"gpt_icon":0},{"id":"2438336323","title":"京东健康与正官庄\"中韩人参研讨会\"发布相关研究成果","url":"https://stock-news.laohu8.com/highlight/detail?id=2438336323","media":"美通社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2438336323?lang=zh_cn&edition=full","pubTime":"2024-05-28 07:00","pubTimestamp":1716850800,"startTime":"0","endTime":"0","summary":"京东健康与正官庄联合举办的“中韩人参研讨会”及高丽人参学会学术大会发布相关研究成果 在当天的研讨会中,中医师、中医药学专家、大学教授、研究员等共计100余人出席,中韩两国的专家们对人参、红参、西洋参在增强免疫力,缓解疲劳及预防呼吸道疾病,提升学习能力、记忆力、专注力等方面的各种功效进行了重点说明并分享了各自的研究成果 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4423716_ZH23716_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["ADHD","KTCIY"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.alcobra-pharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0177},{"period":"1month","weight":0.0061},{"period":"3month","weight":0.0527},{"period":"6month","weight":0.1101},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.2374}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Alcobra Ltd.在以色列注册,并于2008年2月7日开始运营。该公司是一家新兴生物制药公司,主要致力于治疗神经干扰的专利药物开发与商业化,比如注意力缺陷多动症。公司正对药物MG01C1进行更多的临床试验,如果试验成功将向美国食品药品管理局和其他国家的监管机构申请销售。公司还没有通过销售产品取得收入,也不预期产生巨大收入,除非MG01C1获得销售许可并且商业化。因此,公司尚处于发展阶段,正如ASC所定义的“发展阶段实体”。","exchange":"NASDAQ","name":"Alcobra Ltd.","nameEN":"Alcobra"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Alcobra Ltd.(ADHD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Alcobra Ltd.(ADHD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Alcobra Ltd.,ADHD,Alcobra Ltd.股票,Alcobra Ltd.股票老虎,Alcobra Ltd.股票老虎国际,Alcobra Ltd.行情,Alcobra Ltd.股票行情,Alcobra Ltd.股价,Alcobra Ltd.股市,Alcobra Ltd.股票价格,Alcobra Ltd.股票交易,Alcobra Ltd.股票购买,Alcobra Ltd.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Alcobra Ltd.(ADHD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Alcobra Ltd.(ADHD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}